Tim Loh
Bloomberg
New York, NY, United States
Contact Tim
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Tim:
Europe Health Officials Oppose Restrictions on China Travel
European health officials called screenings and restrictions on travelers from China unjustified, a stark contrast to the growing number of countries calling for tougher measures. → Read More
Why Nasal Sprays Are Poised to Be the Next Weapon for Fighting Covid
Meissa Vaccines says its approach can dramatically reduce transmission. → Read More
Coronavirus + Flu = ‘Flurona’: Should You Be Worried About It?
It’s been dubbed flurona: when a person is infected with the influenza virus and the Covid-19 coronavirus, either simultaneously or back-to-back. Cases are being reported around the globe, and experts say they are likely to grow as the more contagious omicron variant becomes more prevalent. The phenomenon, however, isn’t exactly new. Reports of such “co-infections” go back to early 2020. → Read More
Germans Line Up at Vaccine Centers as Booster Push Accelerates
Germany’s sluggish Covid vaccine campaign is rattling back to life, with many snapping up online appointments for shots and others enduring hours of lines in the cold to receive more protection against the coronavirus. → Read More
Germany’s Coronavirus Crisis Is Getting Out of Control
Germany’s Covid crisis is about to go from bad to worse, setting the stage for a grim Christmas in Europe. With infections surging relentlessly and authorities slow to act amid a change in power, experts warn that serious cases and deaths will keep climbing. With intensive-care units all but filled in some regions, Europe’s largest economy faces its biggest test yet of the pandemic. → Read More
Europe Goes After the Unvaccinated to Fight Winter Virus Surge
It’s getting harder to be a vaccine holdout in Europe and continue with life as usual. As governments battle another wave of the outbreak, new restrictions are being introduced, many aimed at the unvaccinated. That’s adding to the pressure on those who’ve resisted the shot so far. → Read More
Nike’s ‘Super Shoes’ Spark Race to Outfit the World’s Runners
The footwear industry is betting technology, like carbon plates, that helped elite runners smash records will ignite sales. → Read More
Adidas falls as production worries outweigh rebound in sales
Adidas AG fell the most in four months as investors looked past a modest increase in profit guidance and focused instead on weaker demand in China and factory shutdowns in Vietnam. → Read More
Adidas Falls as Production Worries Outweigh Rebound in Sales
Adidas AG fell the most in four months as investors looked past a modest increase in profit guidance and focused instead on weaker demand in China and factory shutdowns in Vietnam. → Read More
Bayer to Set Aside $4.5 Billion for Potential Roundup Claims
Bayer AG will set aside $4.5 billion in the second quarter to cover potential future exposure tied to its Roundup weedkiller. → Read More
Adidas CEO sees sneakers and t-shirts in back-to-office fashion
Adidas AG’s Kasper Rorsted doesn’t yet know how much his employees will keep working from home in the years to come, but he’s pretty sure those at other companies will start resembling his sportswear-clad staff. → Read More
A New Wave of Vaccines Is Coming, and They’re Not All Also-Rans
Dozens of companies are developing shots—and some will likely succeed as Covid lingers. → Read More
Need for second Pfizer vaccine dose underscored by U.K. study
People who haven’t fought off COVID-19 before are still vulnerable to infection from variants after getting the first dose of Pfizer Inc. and BioNTech SE’s vaccine, underscoring the need for fast and full inoculation regimens, according to a U.K. study published Friday. → Read More
Golf Resurgence During Covid Boosts Puma as Nike, Adidas Miss Out
Golf is enjoying a coronavirus-fueled comeback, rewarding Puma SE for sticking with the club-and-ball sport. → Read More
The Uncertain Science Behind Vaccine Passports
Questions regarding the efficacy and duration of competing shots stoke concern about using vaccination status as the metric to allow travel. → Read More
Germany is latest country to halt use of AstraZeneca COVID shot
Germany is halting the use of AstraZeneca Plc’s Covid-19 vaccine, joining a dozen or so other European countries taking the precautionary step amid concerns about its safety. → Read More
Adidas to boost e-commerce, recycled gear in five-year plan
Adidas AG is looking to increase sales by as much as 10% annually through 2025 as it doubles down on e-commerce and sustainable materials. → Read More
Pfizer-BioNTech COVID shot neutralizes Brazilian strain in lab
The COVID-19 vaccine from Pfizer Inc. and BioNTech SE showed a high ability to neutralize coronavirus strains first detected in Brazil, the U.K. and South Africa, according to a new study. → Read More
Glaxo, CureVac team up to create next wave of COVID-19 shots
GlaxoSmithKline Plc and CureVac NV joined forces to create next-generation Covid-19 messenger RNA vaccines that could help protect against multiple variants of the pathogen as infections continue to rise. → Read More
EU's push for vaccine supplies gets help from Bayer agreement
Bayer AG agreed to produce CureVac NV’s experimental coronavirus vaccine to boost the rollout of a promising shot as European Union governments scramble for additional supplies to spur a plodding campaign. → Read More